Israel Englander Cyteir Therapeutics, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$2.84 - $3.13 $1.23 Million - $1.35 Million
431,486 Added 2105.43%
451,980 $1.37 Million
Q2 2023

Aug 14, 2023
SELL
$1.74 - $2.6 $110,110 - $164,533
-63,282 Reduced 75.54%
20,494 $53,000
Q1 2023

May 15, 2023
SELL
$1.47 - $1.84 $140,517 - $175,885
-95,590 Reduced 53.29%
83,776 $152,000
Q4 2022

Feb 14, 2023
BUY
$1.18 - $1.76 $70,955 - $105,832
60,132 Added 50.43%
179,366 $296,000
Q3 2022

Nov 14, 2022
SELL
$1.99 - $4.05 $15,750 - $32,055
-7,915 Reduced 6.22%
119,234 $229,000

Others Institutions Holding CYT

# of Institutions
2
Shares Held
2.47M
Call Options Held
0
Put Options Held
0
View Full List

About Cyteir Therapeutics, Inc.

CYT Quotes by TradingView
  • Ticker CYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,413,400
  • Market Cap $107M
  • Description
  • Cyteir Therapeutics, Inc., a clinical-stage biotechnology company, develops and commercializes the next-generation of precision oncology medicines. Its lead product CYT-0851, a novel, oral, once-daily, small molecule drug candidate that is in Phase I/II clinical trial for monotherapy in solid tumors and hematologic malignancies, as well as for c...
More about CYT
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email